Browse by author
Lookup NU author(s): Kate LanyiORCiD,
Professor Dawn Craig,
Dr Christopher Marshall
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
To facilitate effective targeted COVID-19 vaccination strategies, it is important to understand reasons for vaccine hesitancy where uptake is low. Artificial intelligence (AI) techniques offer an opportunity for real-time analysis of public attitudes, sentiments, and key discussion topics from sources of soft-intelligence, including social media data. In this work, we explore the value of soft-intelligence, leveraged using AI, as an evidence source to support public health research. As a case study, we deployed a natural language processing (NLP) platform to rapidly identify and analyse key barriers to vaccine uptake from a collection of geo-located tweets from London, UK. We developed a search strategy to capture COVID-19 vaccine related tweets, identifying 91,473 tweets between 30 November 2020 and 15 August 2021. The platform's algorithm clustered tweets according to their topic and sentiment, from which we extracted 913 tweets from the top 12 negative sentiment topic clusters. These tweets were extracted for further qualitative analysis. We identified safety concerns; mistrust of government and pharmaceutical companies; and accessibility issues as key barriers limiting vaccine uptake. Our analysis also revealed widespread sharing of vaccine misinformation amongst Twitter users. This study further demonstrates that there is promising utility for using off-the-shelf NLP tools to leverage insights from social media data to support public health research. Future work to examine where this type of work might be integrated as part of a mixed-methods research approach to support local and national decision making is suggested.
Author(s): Lanyi K, Green R, Craig D, Marshall C
Publication type: Article
Publication status: Published
Journal: Frontiers in Digital Health
Print publication date: 24/01/2022
Online publication date: 24/01/2022
Acceptance date: 30/12/2021
ISSN (electronic): 2673-253X
PubMed id: PMC8818664
Altmetrics provided by Altmetric